BioMotiv, the for-profit accelerator of The Harrington Project, is the lead funder of Koutif Therapeutics. BioMotiv aims to advance a portfolio of discoveries into new medicines through an innovative, mission-driven model that efficiently aligns capital and collaborations for the benefit of inventors and investors, and ultimately physicians and patients.
BECOME A PARTNER
We are open to partnering with other organizations. If you or your organization is interested in partnering with Koutif Therapeutics, please contact us via the form below.